It does appear well over done the sell off given the results...

It does appear well over done the sell off given the results were a bit lower than hoped for but non the less a reasonable outcome given the uncertain commercial world environment they operated in.

The main concern appears to be the out of left field medical devices investment. Pretty much a 'private' company type of action which has legitimately rattled investors as they were not in the company for that riskier exposure.

Cash in bank is high and thus business runs on an extremely low p/e whether historic or with a bit of growth factored in. Happy to pick away again down in the teens.